Evidence map›Paper›PMID 16849398›Full record

ReviewSchizophrenia bulletin2006

Enhancing validity in co-occurring disorders treatment research.

Gregory J McHugo, Robert E Drake, Mary F Brunette, Haiyi Xie, Susan M Essock, Alan I Green

Abstract readReview
In one paragraph

Review in Schizophrenia bulletin, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. The effects of residential dual diagnosis treatment on alcohol abuse.Journal of systems and integrative neuroscience · 2017
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Management of persons with co-occurring severe mental illness and substance use disorder: program implications.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2007
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Gregory J McHugoDartmouth Psychiatric Research Center, 2 Whipple Place, Suite 202, Lebanon, NH 03766, USA. gregory.mchugo@dartmouth.edu
Robert E Drake
Mary F Brunette
Haiyi Xie
Susan M Essock
Alan I Green

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the high prevalence of co-occurring mental health and substance-use disorders, there has been a relative lack of treatment research with this population, and the existing research often has limited validity. This article explores some of the barriers to the conduct of research on promising interventions for substance-abuse treatment for people with co-occurring disorders, using the concepts of external and ecological validity to make recommendations for future investigation. The central recommendation is to move rapidly from efficacy studies to more credible and valid effectiveness studies, in order to facilitate the adoption of evidence-based interventions in routine practice settings.

Indexed as

ComorbidityDiagnosis, Dual (Psychiatry)HumansRandomized Controlled Trials as TopicReproducibility of ResultsResearchSchizophreniaSubstance-Related DisordersTreatment Outcome

Identifiers

PMID16849398
PMCPMC2632278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.